CardioNet Inc.

CardioNet Inc.

CardioNet Inc. was founded in 1998 as a commercial entity developing mobile cardiac outpatient telemetry (MCOT) technology. The company went public in 2008 and is now a wholly owned subsidiary of BioTelemetry Inc., which itself was acquired by Royal Philips in 2021 (per SEC filings). The wealth origin is not applicable — this is a corporate entity, not a private family office. The company's revenue model centers on providing diagnostic services for cardiac arrhythmias, including event monitoring, Holter monitoring, and extended-wear patches. CardioNet targets healthcare providers, hospitals, and cardiology practices, primarily in the United States. The firm does not disclose AUM or deployment as it does not manage external capital. No recent operational events were reliably sourced from the limited inputs. The firm employs an undisclosed number of professionals; its team size is not publicly documented beyond standard SEC filings. No adjacent vehicles or philanthropic structures are known. CardioNet's structural differentiator lies in its remote cardiac monitoring model, which competes with larger players like iRhythm Technologies. However, this fact holds limited relevance for family-office or allocator audiences, as the entity operates as a non-investment public-company subsidiary under Philips.